v3.25.4
Consolidated statement of comprehensive loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating expenses      
Research and development [1] $ (38,765) $ (35,016) $ (29,821)
General and administration (21,953) (15,296) (11,401)
Loss from operations (60,718) (50,312) (41,222)
Finance income 11,128 9,873 8,978
Finance expense (463) (717) (723)
Movement of expected credit loss 42 66 1
Foreign exchange gain/(loss) 1,753 2,129 (2,621)
Total other income 12,460 11,351 5,635
Loss before tax (48,258) (38,961) (35,587)
Tax charge/(credit) 0 0 0
Loss for the year (48,258) (38,961) (35,587)
Items that may be reclassified to profit or loss      
Fair value movement on marketable securities (127) (173) (95)
Currency translation adjustment 785 (2,054) 2,528
Total comprehensive loss for the year (47,600) (41,188) (33,154)
Attributable to owners:      
Loss for the year (48,258) (38,961) (35,587)
Total comprehensive loss for the year $ (47,600) $ (41,188) $ (33,154)
Loss per share      
Basic loss per share (in dollars per share) $ (0.79) $ (0.75) $ (0.68)
Diluted loss per share (in dollars per share) $ (0.79) $ (0.75) $ (0.68)
[1] Depreciation and other expenses have been reclassified to external research and development expenses for all periods presented as it provides more relevant information.